LivADEK-B

Liver Support Supplement

Branched Chain Amino Acids Supplementation for People with Chronic Liver Disease and Liver Cancer

Advanced liver diseases with cirrhosis are commonly associated with malnutrition and life-threatening ammonia-related hepatic encephalopathy. The body store of Branched Chain Amino Acids (BCAA) is often depleted in people with advanced liver disease. Oral supplementation of BCAA with LivADEK-B boosts body stores of BCAA, help detoxify ammonia and prevents hepatic encephalopathy.

Benefits of BCAA Supplementation

Features

Preparation

Caution

American Association of Study of Liver Disease Practice Guidelines recommend use of BCAA as an alternative or additional treatment of hepatic encephalopathy that is nonresponsive to conventional therapy

American Association of Study of Liver Disease Practice Guidelines recommend BCAA supplementation to achieve and maintain nitrogen (protein) in patients intolerant of dietary protein

Reference:

  1. Marchesini G, et al. J Hepatol 1990;11:92-101.
  2. Gluud LL, et al. Metab Brain Dis 2013;28:221-225.
  3. Gluud LL, et al. J Nutr 2013;143:1263-1268.
  4. Gluud LL, et al. Cochrane Database of Systematic Reviews 2017, Issue 5. Art. No.: CD001939. DOI: 10.1002/14651858.CD001939.pub4
  5. FG Romeiro et al. NeuroImage: Clinical 19 (2018) 302–310
  6. Nishitani S, et al. Hepatol Res 2004;30S:19–24
  7. Marchesini G, et al. Gastroenterology 2003;124:1792–801.
  8. Nakaya Y, et al. Nutrition 2007; 23:113–20.
  9. The San-in Group of Liver Surgery. Br J Surg 1997; 84:1525–31.
  10. Muto Y, et al. Clin Gastroenterol Hepatol.2005 Jul;3(7):705-13.